2006•Journal of Clinical NeurologyRequires access

Therapeutic effect observation of Neurotropin in the treatment of senile postherpetic neuralgia

Zhang Xian-ju

Open publisher page 0 citations

Abstract

Objective To discuss the efficacy of Neurotropin in the treatment of senile postherpes neuralgia.Methods 58 senile patients with postherpes neuralgia were randomly divided into Neurotropin group and Carbamazepine group. Before and after treatment, symptoms and signs of neuropathy including pain and numbness were evaluated by vision ambiguity scales(VAS). The side effects of drugs were also observed.Results 2,4,6 weeks of post-therapy,the VAS of Neurotropin group was decreased obviously than that of pretherapy (all P0.01). The improvement rate of pain in Neurotropin group was significantly better than that of the Carbamazepine group (80% vs 46.4%, P0.05). There was no obvious adverse effect in two groups.Conclusion Neurotropin is effective in the treatment of senile postherpes neuralgia, and is better than Carbamazepine.

About this research paper

What this paper is about

Objective To discuss the efficacy of Neurotropin in the treatment of senile postherpes neuralgia.Methods 58 senile patients with postherpes neuralgia were randomly divided into Neurotropin group and Carbamazepine group. Before and after treatment, symptoms and signs of neuropathy including pain and numbness were evaluated by vision ambiguity scales(VAS). The side effects of drugs were also observed.Results 2,4,6 weeks of post-therapy,the VAS of Neurotropin group was decreased obviously than that of pretherapy (all P0.01). The improvement rate of pain in Neurotropin group was significantly better than that of the Carbamazepine group (80% vs 46.4%, P0.05). There was no obvious adverse effect in two groups.Conclusion Neurotropin is effective in the treatment of senile postherpes neuralgia, and is better than Carbamazepine.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To discuss the efficacy of Neurotropin in the treatment of senile postherpes neuralgia.Methods 58 senile patients with postherpes neuralgia were randomly divided into Neurotropin group and Carbamazepine group. Before and after treatment, symptoms and signs of neuropathy including pain and numbness were evaluated by vision ambiguity scales(VAS). The side effects of drugs were also observed.Results 2,4,6 weeks of post-therapy,the VAS of Neurotropin group was decreased obviously than that of pretherapy (all P0.01). The improvement rate of pain in Neurotropin group was significantly better than that of the Carbamazepine group (80% vs 46.4%, P0.05). There was no obvious adverse effect in two groups.Conclusion Neurotropin is effective in the treatment of senile postherpes neuralgia, and is better than Carbamazepine.

Key concepts: Carbamazepine, Postherpetic neuralgia, Medicine, Neuralgia, Anesthesia, Therapeutic effect, Adverse effect, Neuropathic pain

Related papers

Back to paper searchBrowse research topicsOriginal source
Therapeutic effect observation of Neurotropin in the treatment of senile postherpetic neuralgia — Research Paper | ScholarLens